In focus · trending topic

somatostatin analog

1 stories · following the connections

RadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumors

By Nasdaq OMXJan 10, 2018, 10:00 AM UTC